767 — Zhong Ji Longevity Science Cashflow Statement
0.000.00%
Last trade - 00:00- HK$213.15m
- HK$211.13m
- HK$166.18m
Annual cashflow statement for Zhong Ji Longevity Science, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.17 | 6.96 | 9.32 | 4.75 | -33.2 |
| Depreciation | |||||
| Non-Cash Items | 48.1 | -0.629 | 31.3 | -23.5 | -7.41 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -240 | -51.9 | -32.8 | 27.1 | -27.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -199 | -41.2 | 12 | 15.7 | -61.1 |
| Capital Expenditures | -1.35 | -0.889 | -1.03 | 0 | -0.708 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 78.6 | 5.39 | 17.6 | 0.382 | 12.2 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 77.3 | 4.5 | 16.6 | 0.382 | 11.5 |
| Financing Cash Flow Items | 0 | 6.93 | -6.93 | -0.606 | -0.536 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.43 | 3.44 | -7.45 | 6.02 | 15.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -114 | -21.4 | 40.6 | 21 | -33.2 |